{
  "actions": [
    {
      "acted_at": "2020-07-09", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2020-07-09", 
      "action_code": "", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2020-07-09", 
      "action_code": "H11100", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "text": "Referred to the House Committee on Ways and Means.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr7537-116", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "02"
    }
  ], 
  "congress": "116", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2020-07-09", 
  "number": "7537", 
  "official_title": "To amend the Internal Revenue Code of 1986 to provide an exception from the passive loss rules for investments in specified medical research small business pass-thru entities.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr14-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Infectious Disease Therapies Research and Innovation Act of 2020", 
  "sponsor": {
    "bioguide_id": "K000376", 
    "district": "16", 
    "name": "Kelly, Mike", 
    "state": "PA", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2020-07-09", 
  "subjects": [
    "Accounting and auditing", 
    "Advanced technology and technological innovations", 
    "Business investment and capital", 
    "Income tax credits", 
    "Infectious and parasitic diseases", 
    "Medical research", 
    "Small business", 
    "Tax administration and collection, taxpayers", 
    "Taxation"
  ], 
  "subjects_top_term": "Taxation", 
  "summary": null, 
  "titles": [
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Infectious Disease Therapies Research and Innovation Act of 2020", 
      "type": "display"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Infectious Disease Therapies Research and Innovation Act of 2020", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Internal Revenue Code of 1986 to provide an exception from the passive loss rules for investments in specified medical research small business pass-thru entities.", 
      "type": "official"
    }
  ], 
  "updated_at": "2020-12-10T16:19:46Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr7537.xml"
}